Recherche
-
Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
(NPJ vaccines. vol. 8, n° 1, pp. 174, 2023-11-08)Article de revueLibre accès -
Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo
(Cell Reports. vol. 42, n° 9, pp. 113101, 2023-09-26)Article de revueLibre accès -
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
(PLoS Neglected Tropical Diseases. vol. 18, n° 4, pp. e0011500, 2024-04-11)Article de revueLibre accès -
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART
(International Journal of Infectious Diseases. vol. 146, pp. 107110, 2024-05-31)Article de revueLibre accès -
Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption
(Clinical Infectious Diseases. pp. ciae235, 2024-05-31)Article de revue